Iván Hernández-Neuta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Iván Hernández-Neuta has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Mats Nilsson
Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden
12 shared publications - Felix Neumann
Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
4 shared publications Annika Ahlford
Devyser AB, Instrumentvägen 19, 126 53 Stockholm, Sweden
3 shared publicationsJuan Carlos Palomino
Laboratory of Microbiology, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, Ghent, Belgium
3 shared publications- María Mercedes Zambrano
Corpogen Research Center, Bogotá, Colombia; Dirección de Investigaciones y Transferencia de Conocimiento, Universidad Central , Bogotá, 110311
3 shared publications - Patricia Del Portillo
Departamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia
3 shared publications
Latest Publications
- Open Access
- 23 August 2023
- Published by Springer Nature in BMC Biotechnology
- Vol. 23 (1) , 1-10
Highly multiplexed targeted sequencing strategy for infectious disease surveillance
Background: Global efforts to characterize diseases of poverty are hampered by lack of affordable and comprehensive detection platforms, resulting in suboptimal allocation of health care resources and inefficient disease control. Next generation sequencing (NGS) can provide accurate data and high throughput. However, shotgun and metagenome-based NGS approaches are limited by low concentrations of microbial DNA in clinical samples, requirements for tailored sample and library preparations plus extensive bioinformatics analysis. Here, we adapted molecular inversion probes (MIPs) as a cost-effective target enrichment approach to characterize microbial infections from blood samples using short-read sequencing. We designed a probe panel targeting 2 bacterial genera, 21 bacterial and 6 fungi species and 7 antimicrobial resistance markers (AMRs). Results: Our approach proved to be highly specific to detect down to 1 in a 1000 pathogen DNA targets contained in host DNA. Additionally, we were able to accurately survey pathogens and AMRs in 20 out of 24 samples previously profiled with routine blood culture for sepsis. Conclusions: Overall, our targeted assay identifies microbial pathogens and AMRs with high specificity at high throughput, without the need for extensive sample preparation or bioinformatics analysis, simplifying its application for characterization and surveillance of infectious diseases in medium- to low- resource settings.
- 23 August 2023
- Published by Springer Nature in BMC Biotechnology
- Vol. 23 (1) , 1-10
Open AccessHighly multiplexed targeted sequencing strategy for infectious disease surveillance
Background: Global efforts to characterize diseases of poverty are hampered by lack of affordable and comprehensive detection platforms, resulting in suboptimal allocation of health care resources and inefficient disease control. Next generation sequencing (NGS) can provide accurate data and high throughput. However, shotgun and metagenome-based NGS approaches are limited by low concentrations of microbial DNA in clinical samples, requirements for tailored sample and library preparations plus extensive bioinformatics analysis. Here, we adapted molecular inversion probes (MIPs) as a cost-effective target enrichment approach to characterize microbial infections from blood samples using short-read sequencing. We designed a probe panel targeting 2 bacterial genera, 21 bacterial and 6 fungi species and 7 antimicrobial resistance markers (AMRs). Results: Our approach proved to be highly specific to detect down to 1 in a 1000 pathogen DNA targets contained in host DNA. Additionally, we were able to accurately survey pathogens and AMRs in 20 out of 24 samples previously profiled with routine blood culture for sepsis. Conclusions: Overall, our targeted assay identifies microbial pathogens and AMRs with high specificity at high throughput, without the need for extensive sample preparation or bioinformatics analysis, simplifying its application for characterization and surveillance of infectious diseases in medium- to low- resource settings.
- Open Access
- 1 December 2018
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 64 (12) , 1704-1712
Padlock Probe Assay for Detection and Subtyping of Seasonal Influenza
BACKGROUND: Influenza remains a constant threat worldwide, and WHO estimates that it affects 5% to 15% of the global population each season, with an associated 3 to 5 million severe cases and up to 500000 deaths. To limit the morbidity and the economic burden of influenza, improved diagnostic assays are needed. METHODS: We developed a multiplexed assay for the detection and subtyping of seasonal influenza based on padlock probes and rolling circle amplification. The assay simultaneously targets all 8 genome segments of the 4 circulating influenza variants—A(H1N1), A(H3N2), B/Yamagata, and B/Victoria—and was combined with a prototype cartridge for inexpensive digital quantification. Characterized virus isolates and patient nasopharyngeal swabs were used for assay design and analytical validation. The diagnostic performance was assessed by blinded testing of 50 clinical samples analyzed in parallel with a commercial influenza assay, Simplexa™ Flu A/B & RSV Direct. RESULTS: The assay had a detection limit of 18 viral RNA copies and achieved 100% analytical and clinical specificity for differential detection and subtyping of seasonal circulating influenza variants. The diagnostic sensitivity on the 50 clinical samples was 77.5% for detecting influenza and up to 73% for subtyping seasonal variants. CONCLUSIONS: We have presented a proof-of-concept padlock probe assay combined with an inexpensive digital readout for the detection and subtyping of seasonal influenza strains A and B. The demonstrated high specificity and multiplexing capability, together with the digital quantification, established the assay as a promising diagnostic tool for seasonal influenza.
- 1 December 2018
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 64 (12) , 1704-1712
Open AccessPadlock Probe Assay for Detection and Subtyping of Seasonal Influenza
BACKGROUND: Influenza remains a constant threat worldwide, and WHO estimates that it affects 5% to 15% of the global population each season, with an associated 3 to 5 million severe cases and up to 500000 deaths. To limit the morbidity and the economic burden of influenza, improved diagnostic assays are needed. METHODS: We developed a multiplexed assay for the detection and subtyping of seasonal influenza based on padlock probes and rolling circle amplification. The assay simultaneously targets all 8 genome segments of the 4 circulating influenza variants—A(H1N1), A(H3N2), B/Yamagata, and B/Victoria—and was combined with a prototype cartridge for inexpensive digital quantification. Characterized virus isolates and patient nasopharyngeal swabs were used for assay design and analytical validation. The diagnostic performance was assessed by blinded testing of 50 clinical samples analyzed in parallel with a commercial influenza assay, Simplexa™ Flu A/B & RSV Direct. RESULTS: The assay had a detection limit of 18 viral RNA copies and achieved 100% analytical and clinical specificity for differential detection and subtyping of seasonal circulating influenza variants. The diagnostic sensitivity on the 50 clinical samples was 77.5% for detecting influenza and up to 73% for subtyping seasonal variants. CONCLUSIONS: We have presented a proof-of-concept padlock probe assay combined with an inexpensive digital readout for the detection and subtyping of seasonal influenza strains A and B. The demonstrated high specificity and multiplexing capability, together with the digital quantification, established the assay as a promising diagnostic tool for seasonal influenza.
- 1 November 2018
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 273, 742-750
QCM mass underestimation in molecular biotechnology: Proximity ligation assay for norovirus detection as a case study
- 1 November 2018
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 273, 742-750
QCM mass underestimation in molecular biotechnology: Proximity ligation assay for norovirus detection as a case study
- Top Cited PapersOpen Access
- 6 August 2018
- Published by Wiley in Journal of Internal Medicine
- Vol. 285 (1) , 19-39
Smartphone‐based clinical diagnostics: towards democratization of evidence‐based health care
Recent advancements in bioanalytical techniques have led to the development of novel and robust diagnostic approaches that hold promise for providing optimal patient treatment, guiding prevention programs and widening the scope of personalized medicine. However, these advanced diagnostic techniques are still complex, expensive and limited to centralized healthcare facilities or research laboratories. This significantly hinders the use of evidence‐based diagnostics for resource‐limited settings and the primary care, thus creating a gap between healthcare providers and patients, leaving these populations without access to precision and quality medicine. Smartphone‐based imaging and sensing platforms are emerging as promising alternatives for bridging this gap and decentralizing diagnostic tests offering practical features such as portability, cost‐effectiveness and connectivity. Moreover, towards simplifying and automating bioanalytical techniques, biosensors and lab‐on‐a‐chip technologies have become essential to interface and integrate these assays, bringing together the high precision and sensitivity of diagnostic techniques with the connectivity and computational power of smartphones. Here, we provide an overview of the emerging field of clinical smartphone diagnostics and its contributing technologies, as well as their wide range of areas of application, which span from haematology to digital pathology and rapid infectious disease diagnostics.
- 6 August 2018
- Published by Wiley in Journal of Internal Medicine
- Vol. 285 (1) , 19-39
Top Cited PapersOpen AccessSmartphone‐based clinical diagnostics: towards democratization of evidence‐based health care
Recent advancements in bioanalytical techniques have led to the development of novel and robust diagnostic approaches that hold promise for providing optimal patient treatment, guiding prevention programs and widening the scope of personalized medicine. However, these advanced diagnostic techniques are still complex, expensive and limited to centralized healthcare facilities or research laboratories. This significantly hinders the use of evidence‐based diagnostics for resource‐limited settings and the primary care, thus creating a gap between healthcare providers and patients, leaving these populations without access to precision and quality medicine. Smartphone‐based imaging and sensing platforms are emerging as promising alternatives for bridging this gap and decentralizing diagnostic tests offering practical features such as portability, cost‐effectiveness and connectivity. Moreover, towards simplifying and automating bioanalytical techniques, biosensors and lab‐on‐a‐chip technologies have become essential to interface and integrate these assays, bringing together the high precision and sensitivity of diagnostic techniques with the connectivity and computational power of smartphones. Here, we provide an overview of the emerging field of clinical smartphone diagnostics and its contributing technologies, as well as their wide range of areas of application, which span from haematology to digital pathology and rapid infectious disease diagnostics.
- Open Access
- 4 June 2018
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 4 (1) , 9
Correction to: Efficient DNA-assisted synthesis of trans-membrane gold nanowires
Figure 1 and the descriptive text in the Section “SEM characterization of synthesized nanowires” of the previously published version of this Article were erroneous. The authors would like to replace Fig. 1 and section “SEM characterization of synthesized nanowires” with the figure and text below:
- 4 June 2018
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 4 (1) , 9
Open AccessCorrection to: Efficient DNA-assisted synthesis of trans-membrane gold nanowires
Figure 1 and the descriptive text in the Section “SEM characterization of synthesized nanowires” of the previously published version of this Article were erroneous. The authors would like to replace Fig. 1 and section “SEM characterization of synthesized nanowires” with the figure and text below:
- 1 April 2018
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 102, 531-539
Microfluidic magnetic fluidized bed for DNA analysis in continuous flow mode
- 1 April 2018
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 102, 531-539
Microfluidic magnetic fluidized bed for DNA analysis in continuous flow mode
- Open Access
- 12 February 2018
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 4 (1) , 17084
Efficient DNA-assisted synthesis of trans-membrane gold nanowires
Whereas electric circuits and surface-based (bio)chemical sensors are mostly constructed in-plane due to ease of manufacturing, 3D microscale and nanoscale structures allow denser integration of electronic components and improved mass transport of the analyte to (bio)chemical sensor surfaces. This work reports the first out-of-plane metallic nanowire formation based on stretching of DNA through a porous membrane. We use rolling circle amplification (RCA) to generate long single-stranded DNA concatemers with one end anchored to the surface. The DNA strands are stretched through the pores in the membrane during liquid removal by forced convection. Because the liquid–air interface movement across the membrane occurs in every pore, DNA stretching across the membrane is highly efficient. The stretched DNA molecules are transformed into trans-membrane gold nanowires through gold nanoparticle hybridization and gold enhancement chemistry. A 50 fM oligonucleotide concentration, a value two orders of magnitude lower than previously reported for flat surface-based nanowire formation, was sufficient for nanowire formation. We observed nanowires in up to 2.7% of the membrane pores, leading to an across-membrane electrical conductivity reduction from open circuit to <20 Ω. The simple electrical read-out offers a high signal-to-noise ratio and can also be extended for use as a biosensor due to the high specificity and scope for multiplexing offered by RCA.
- 12 February 2018
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 4 (1) , 17084
Open AccessEfficient DNA-assisted synthesis of trans-membrane gold nanowires
Whereas electric circuits and surface-based (bio)chemical sensors are mostly constructed in-plane due to ease of manufacturing, 3D microscale and nanoscale structures allow denser integration of electronic components and improved mass transport of the analyte to (bio)chemical sensor surfaces. This work reports the first out-of-plane metallic nanowire formation based on stretching of DNA through a porous membrane. We use rolling circle amplification (RCA) to generate long single-stranded DNA concatemers with one end anchored to the surface. The DNA strands are stretched through the pores in the membrane during liquid removal by forced convection. Because the liquid–air interface movement across the membrane occurs in every pore, DNA stretching across the membrane is highly efficient. The stretched DNA molecules are transformed into trans-membrane gold nanowires through gold nanoparticle hybridization and gold enhancement chemistry. A 50 fM oligonucleotide concentration, a value two orders of magnitude lower than previously reported for flat surface-based nanowire formation, was sufficient for nanowire formation. We observed nanowires in up to 2.7% of the membrane pores, leading to an across-membrane electrical conductivity reduction from open circuit to <20 Ω. The simple electrical read-out offers a high signal-to-noise ratio and can also be extended for use as a biosensor due to the high specificity and scope for multiplexing offered by RCA.
- Open Access
- 9 August 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (4) , 509
Real-Time QCM Measurements of Rolling Circle Amplification Products
We demonstrate real-time experimental evidence for mass underestimation, to analyse high molecular weight biomolecules while using Quartz Crystal Microbalance (QCM) platform. For this, we present an experimental evidence with an assay consisting of an aptamer-antibody sandwich model with norovirus-like particles (NoVLPs). We combine this with the proximity ligation assay to generate bulky rolling circle products on a gold spot centralized quartz resonator surface. Real-time monitoring of the assay build-up reflects that bulky NoVLPs and amplified oligonucleotides generate fluctuating signals during measurement using a microfluidic QCM sensor. Such an understanding of mass underestimation for heavier molecules becomes indispensable to get deeper insights into molecular interactions in biotechnology studied using QCM devices.
- 9 August 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (4) , 509
Open AccessReal-Time QCM Measurements of Rolling Circle Amplification Products
We demonstrate real-time experimental evidence for mass underestimation, to analyse high molecular weight biomolecules while using Quartz Crystal Microbalance (QCM) platform. For this, we present an experimental evidence with an assay consisting of an aptamer-antibody sandwich model with norovirus-like particles (NoVLPs). We combine this with the proximity ligation assay to generate bulky rolling circle products on a gold spot centralized quartz resonator surface. Real-time monitoring of the assay build-up reflects that bulky NoVLPs and amplified oligonucleotides generate fluctuating signals during measurement using a microfluidic QCM sensor. Such an understanding of mass underestimation for heavier molecules becomes indispensable to get deeper insights into molecular interactions in biotechnology studied using QCM devices.
- Open Access
- 1 July 2017
- Published by Elsevier in Cell Reports
- Vol. 20 (1) , 251-263
Analysis of IAV Replication and Co-infection Dynamics by a Versatile RNA Viral Genome Labeling Method
- 1 July 2017
- Published by Elsevier in Cell Reports
- Vol. 20 (1) , 251-263
Open AccessAnalysis of IAV Replication and Co-infection Dynamics by a Versatile RNA Viral Genome Labeling Method
- Open Access
- 17 January 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 13913
Targeted DNA sequencing and in situ mutation analysis using mobile phone microscopy
Molecular diagnostics is typically outsourced to well-equipped centralized laboratories, often far from the patient. We developed molecular assays and portable optical imaging designs that permit on-site diagnostics with a cost-effective mobile-phone-based multimodal microscope. We demonstrate that targeted next-generation DNA sequencing reactions and in situ point mutation detection assays in preserved tumour samples can be imaged and analysed using mobile phone microscopy, achieving a new milestone for tele-medicine technologies.
- 17 January 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 13913
Open AccessTargeted DNA sequencing and in situ mutation analysis using mobile phone microscopy
Molecular diagnostics is typically outsourced to well-equipped centralized laboratories, often far from the patient. We developed molecular assays and portable optical imaging designs that permit on-site diagnostics with a cost-effective mobile-phone-based multimodal microscope. We demonstrate that targeted next-generation DNA sequencing reactions and in situ point mutation detection assays in preserved tumour samples can be imaged and analysed using mobile phone microscopy, achieving a new milestone for tele-medicine technologies.